Combined endothelin receptor blockade evokes enhanced vasodilatation in patients with atherosclerosis

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 22, Issue 4, 2002, Pages 674-679

  Böhm, Felix ^a   Ahlborg, Gunvor ^a   Johansson, Bo Lennart ^a   Hansson, Lars Olof ^a   Pernow, John ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Atherosclerosis; Endothelin; Receptors; Regional blood flow

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR ANTAGONIST; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE;

ADULT; AGED; ARM BLOOD FLOW; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL TONE; CLINICAL ARTICLE; CONTROLLED STUDY; HEMODYNAMICS; HUMAN; MALE; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; RECEPTOR BLOCKING; VASOCONSTRICTION; VASODILATATION; VEIN OCCLUSION PLETHYSMOGRAPHY;

ANTIHYPERTENSIVE AGENTS; ARTERIOSCLEROSIS; CASE-CONTROL STUDIES; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; FOREARM; HUMANS; MALE; MIDDLE AGED; OLIGOPEPTIDES; PEPTIDES, CYCLIC; PIPERIDINES; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; RECEPTORS, ENDOTHELIN; REGIONAL BLOOD FLOW; UP-REGULATION; VASODILATION;

EID: 0036120406     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000012804.63152.60     Document Type: Article

References (29)

1. A novel potent vasoconstrictor peptide produced by vascular endothelial cells
2. The human endothelin family: Three structurally and pharmacologically distinct isopeptides predicted by three separate genes
3. Cloning and expression of a cDNA encoding an endothelin receptor
4. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor
5. Contribution of endogenous generation of endothelin-I to basal vascular tone
6. Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade
7. The role of endothelin in the pathogenesis of atherosclerosis
8. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis
9. Tissue endothelin-I immunoreactivity in the active coronary atherosclerotic plaque
10. Up-regulation of endothelin-B receptors in atherosclerotic human coronary arteries
11. Increased immunoreacfivity of endothelin-I and endothelin B receptor in human atherosclerotic lesions: A possible role in atherogenesis
12. Enhanced vasoconstrictor response to endothelin B receptor stimulation in patients with atherosclerosis
13. Potent vasoconstrictor effects and clearance of endothelin in the human forearm
14. Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788
15. In vitro biological profile of a highly potent novel endothelin (ET) antagonist BQ-123 selective for the ETA receptor
16. Transient triglyceridemia decreases vascular reactivity in young, healthy men without risk factors for coronary heart disease
17. Characteristics of endothelin A and B binding sites and their vascular effects in pig peripheral tissues
18. Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum
19. Role of endothelin in the increased vascular tone of patients with essential hypertension
20. Increased activity of endogenous endothelin in patients with hypercholesterolemia
21. Role of endothelin-I in the active constriction of human atherosclerotic coronary arteries
22. Clearance of circulating endothelin-I by ETB receptors in rats
23. Synergistic inhibition by BQ-123 and BQ-788 of endothelin-I-induced contractions of the rabbit pulmonary artery
24. Activation of endothelin ETA receptors masks the constrictor role of endothelin ETB receptors in rat isolated small mesenteric arteries
25. Necessity of dual blockade of endothelin ETA and ETB receptor subtypes for antagonism of endothelin-I-induced contraction in human bronchi
26. Phosphoramidon inhibition of the in vivo conversion of big endothelin-I to endothelin-I in the human forearm
27. Endothelium-mediated coronary blood flow modulation in humans: Effects of age, atherosclerosis, hypercholesterolemia, and hypertension
28. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor
29. Atherosclerosis in the human brachial artery